Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Arteries of the Lower Limbs01:24

Arteries of the Lower Limbs

189
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
189
Seizures: Classification01:13

Seizures: Classification

347
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
347
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

183
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
183
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

551
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
551
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

399
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
399
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

345
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
345

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neurofilament light-chain (Nf-L) as a biomarker in seizures and status epilepticus of varying duration.

Journal of neurology·2026
Same author

Perspectives on the burden of drug-resistant epilepsy and treatment priorities: Findings from a multistakeholder survey.

Epilepsia open·2026
Same author

Women with epilepsy: Evidence-based counseling across the lifespan.

Epilepsia·2026
Same author

Therapeutic Strategies After Discontinuation of Valproate By Females with Epilepsy of Child-Bearing Potential: An Insurance Claims Database Study in France and the United Kingdom.

Clinical drug investigation·2026
Same author

Epilepsy in women of childbearing age: a focused review.

Neurological research and practice·2025
Same author

Non-discontinuation of antiseizure medication in seizure-free patients with epilepsy: Reasons and predictors among neurologists and patients.

Epilepsia·2025
Same journal

[Digital health applications and adherence in depression: a qualitative study from the perspective of healthcare providers].

Der Nervenarzt·2026
Same journal

Der Nervenarzt·2026
Same journal

[Rare genetic diseases with frequent mental symptoms].

Der Nervenarzt·2026
Same journal

Der Nervenarzt·2026
Same journal

Der Nervenarzt·2026
Same journal

[From feeblemindedness to intellectual deficiency : Some comments from the forensic-psychiatric perspective on the replacement of the juridical term in the German Criminal Code (the criminal liability paragraph 20 StGB)].

Der Nervenarzt·2026
See all related articles

Related Experiment Video

Updated: Jul 1, 2025

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.1K

[Epilepsy and pregnancy].

Verena Gaus1, Maria Ilyas-Feldmann2, Bettina Schmitz3

  • 1Epilepsie-Zentrum Berlin-Brandenburg, Klinik und Hochschulambulanz für Neurologie, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Deutschland. verena.gaus@charite.de.

Der Nervenarzt
|March 7, 2024
PubMed
Summary
This summary is machine-generated.

Women with epilepsy require careful family planning. Effective antiseizure medication (ASM) is vital during pregnancy, despite potential risks, to protect both mother and child from seizure-related complications.

Keywords:
Antiseizure medicationBreastfeedingChild developmentMalformationsTreatment recommendations

More Related Videos

Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture
09:06

Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture

Published on: December 22, 2016

9.6K
Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
06:58

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement

Published on: June 25, 2016

19.1K

Related Experiment Videos

Last Updated: Jul 1, 2025

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.1K
Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture
09:06

Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture

Published on: December 22, 2016

9.6K
Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
06:58

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement

Published on: June 25, 2016

19.1K

Area of Science:

  • Neurology
  • Pharmacology
  • Reproductive Health

Context:

  • Epilepsy management in women of childbearing potential necessitates consideration of family planning and reproductive desires.
  • Understanding the interplay between epilepsy, antiseizure medications (ASMs), pregnancy, and child development is critical for optimal patient care.

Purpose:

  • To provide an overview of current data regarding the implications of epilepsy and its treatment on pregnancy and child development.
  • To discuss the interactions between antiseizure medications, hormonal contraception, and pregnancy pharmacokinetics.
  • To present evidence-based treatment recommendations for women with epilepsy who are planning pregnancy or are pregnant.

Summary:

  • Antiseizure medications (ASMs) can interact with contraceptives and alter hormone levels, impacting women with epilepsy.
  • All ASMs carry a risk of congenital malformations, but effective ASM treatment is essential during pregnancy to mitigate seizure-related risks to mother and child.
  • Despite potential risks, most pregnancies in women with epilepsy are uncomplicated when managed appropriately.

Impact:

  • Informs clinical practice regarding the safe and effective management of epilepsy in women of childbearing potential.
  • Highlights the importance of preconception counseling and individualized treatment strategies.
  • Contributes to improved outcomes for both mothers with epilepsy and their children.